Vitamin D compounds and myelodysplastic syndrome.
Okamoto
Ryoko
R
Division of Hematology and Oncology, Cedar-Sinai Medical Center, UCLA School of Medicine, Los Angeles, CA 90048, USA. Ryoko.Okamoto@cshs.org
Akagi
Tadayuki
T
Koeffler
Phillip
P
D006801:Humans; D006934:Hypercalcemia / Q000139:chemically induced; D009190:Myelodysplastic Syndromes / Q000188:drug therapy*; D016896:Treatment Outcome; D014807:Vitamin D / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use*
D014807:Vitamin D